(Q34290060)

1 August 2017

Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis (English)

1 reference

1 August 2017

0 references

1 reference

Koen Andries

1

1 reference

1 August 2017

Tom Gevers

series ordinal

2

1 reference

1 August 2017

Nacer Lounis

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

16 August 2010

1 reference

Antimicrobial Agents and Chemotherapy

1 August 2017

1 reference

1 August 2017

54

1 reference

1 August 2017

4540-4544

1 reference

1 August 2017

11

1 reference

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Biomarkers for tuberculosis disease activity, cure, and relapse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976132

Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study

28 October 2018

1 reference

12 December 2020

Tuberculosis: a global emergency

1 reference

12 December 2020

Experimental models of tuberculosis: can we trust the mouse?

1 reference

12 December 2020

New initiative speeds tuberculosis drug development: novel drug regimens become possible in years, not decades

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00934-10

1 reference

1 August 2017

1 reference

1 August 2017

1 reference